Cargando…

What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review

Liposomes have been attracted considerable attention as phospholipid spherical vesicles, over the past 40 years. These lipid vesicles are valued in biomedical application due to their ability to carry both hydrophobic and hydrophilic agents, high biocompatibility and biodegradability. Various method...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi, Hanieh, Kouchak, Maryam, Mirveis, Zohreh, Hajipour, Fatemeh, Khodarahmi, Mohsen, Rahbar, Nadereh, Handali, Somayeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871273/
https://www.ncbi.nlm.nih.gov/pubmed/36721822
http://dx.doi.org/10.34172/apb.2023.009
_version_ 1784877132701237248
author Abbasi, Hanieh
Kouchak, Maryam
Mirveis, Zohreh
Hajipour, Fatemeh
Khodarahmi, Mohsen
Rahbar, Nadereh
Handali, Somayeh
author_facet Abbasi, Hanieh
Kouchak, Maryam
Mirveis, Zohreh
Hajipour, Fatemeh
Khodarahmi, Mohsen
Rahbar, Nadereh
Handali, Somayeh
author_sort Abbasi, Hanieh
collection PubMed
description Liposomes have been attracted considerable attention as phospholipid spherical vesicles, over the past 40 years. These lipid vesicles are valued in biomedical application due to their ability to carry both hydrophobic and hydrophilic agents, high biocompatibility and biodegradability. Various methods have been used for the synthesis of liposomes, so far and numerous modifications have been performed to introduce liposomes with different characteristics like surface charge, size, number of their layers, and length of circulation in biological fluids. This article provides an overview of the significant advances in synthesis of liposomes via active or passive drug loading methods, as well as describes some strategies developed to fabricate their targeted formulations to overcome limitations of the "first-generation" liposomes.
format Online
Article
Text
id pubmed-9871273
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Tabriz University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-98712732023-01-30 What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review Abbasi, Hanieh Kouchak, Maryam Mirveis, Zohreh Hajipour, Fatemeh Khodarahmi, Mohsen Rahbar, Nadereh Handali, Somayeh Adv Pharm Bull Review Article Liposomes have been attracted considerable attention as phospholipid spherical vesicles, over the past 40 years. These lipid vesicles are valued in biomedical application due to their ability to carry both hydrophobic and hydrophilic agents, high biocompatibility and biodegradability. Various methods have been used for the synthesis of liposomes, so far and numerous modifications have been performed to introduce liposomes with different characteristics like surface charge, size, number of their layers, and length of circulation in biological fluids. This article provides an overview of the significant advances in synthesis of liposomes via active or passive drug loading methods, as well as describes some strategies developed to fabricate their targeted formulations to overcome limitations of the "first-generation" liposomes. Tabriz University of Medical Sciences 2023-01 2022-04-04 /pmc/articles/PMC9871273/ /pubmed/36721822 http://dx.doi.org/10.34172/apb.2023.009 Text en ©2023 The Authors. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required from the authors or the publishers.
spellingShingle Review Article
Abbasi, Hanieh
Kouchak, Maryam
Mirveis, Zohreh
Hajipour, Fatemeh
Khodarahmi, Mohsen
Rahbar, Nadereh
Handali, Somayeh
What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review
title What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review
title_full What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review
title_fullStr What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review
title_full_unstemmed What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review
title_short What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review
title_sort what we need to know about liposomes as drug nanocarriers: an updated review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871273/
https://www.ncbi.nlm.nih.gov/pubmed/36721822
http://dx.doi.org/10.34172/apb.2023.009
work_keys_str_mv AT abbasihanieh whatweneedtoknowaboutliposomesasdrugnanocarriersanupdatedreview
AT kouchakmaryam whatweneedtoknowaboutliposomesasdrugnanocarriersanupdatedreview
AT mirveiszohreh whatweneedtoknowaboutliposomesasdrugnanocarriersanupdatedreview
AT hajipourfatemeh whatweneedtoknowaboutliposomesasdrugnanocarriersanupdatedreview
AT khodarahmimohsen whatweneedtoknowaboutliposomesasdrugnanocarriersanupdatedreview
AT rahbarnadereh whatweneedtoknowaboutliposomesasdrugnanocarriersanupdatedreview
AT handalisomayeh whatweneedtoknowaboutliposomesasdrugnanocarriersanupdatedreview